Doctors test new sedative for kidney transplant surgery
NCT ID NCT07045467
Summary
This study aims to understand how a sedative drug called remimazolam works in people receiving a kidney transplant. Researchers will give the drug to 30 patients during their transplant surgery and closely measure how their bodies process it and how deeply it sedates them. The goal is to gather data to help doctors use this drug more safely and effectively for anesthesia in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shandong First Medical University Hospital
RECRUITINGJinan, Shangdong, 250014, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.